PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHeroin dependence
MeSH D006556 - heroin dependence
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009293:Opioid-related disorders
70 Companies
12 Drugs
$
Success rate
D006556: 
Heroin dependence
28 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBuprenorphine, Naloxone Buprenorphine Naloxone  2014-09-08   
Buprenorphine, Naloxone Cassipa  2018-09-07   
MylanBuprenorphine Buprenorphine  2015-03-06   
Buprenorphine, Naloxone Buprenorphine Naloxone  2018-06-14   
Barr PharmaceuticalsBuprenorphine Buprenorphine  2010-05-07   
Dr Reddys LaboratoriesBuprenorphine, Naloxone Buprenorphine Naloxone  2018-06-14   
Sun Pharmaceutical IndustriesBuprenorphine Buprenorphine  2016-01-29   
Buprenorphine, Naloxone Buprenorphine Naloxone  2016-08-05   
Alkem LaboratoriesBuprenorphine, Naloxone Buprenorphine Naloxone  2021-06-15   
HospiraBuprenorphine Buprenorphine  1996-06-03   
Amneal PharmaceuticalsBuprenorphine Buprenorphine  2020-04-14   
Buprenorphine, Naloxone Buprenorphine Naloxone  2013-02-22   
EthypharmBuprenorphine Buprenorphine  2010-09-24   
Buprenorphine, Naloxone Buprenorphine Naloxone  2015-10-16   
LannettBuprenorphine, Naloxone Buprenorphine Naloxone  2016-09-19   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
56%
5/9
Phase 2
67%
4/6
Phase 3
40%
4/10
Approved: 1Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Buprenorphine
Purdue Pharma
Buprenorphine
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use